| Spliceosome |
1.81 |
8.76e-2 |
101/150 (67.33%) |
SNRPG;SRSF6;SNRPD1;...
|
| DNA replication |
1.70 |
1.23e-1 |
34/36 (94.44%) |
PCNA;RFC5;MCM7;...
|
| Other types of O-glycan biosynthesis |
1.64 |
1.55e-1 |
29/47 (61.7%) |
GALNT6;GALNT1;POFUT1;...
|
| Mismatch repair |
1.61 |
1.56e-1 |
22/23 (95.65%) |
PCNA;RFC5;RFC4;...
|
| Sulfur relay system |
1.57 |
1.74e-1 |
5/8 (62.5%) |
NFS1;TST
|
| Homologous recombination |
1.52 |
2.27e-1 |
35/41 (85.37%) |
RBBP8;MRE11;BRCA1;...
|
| Cysteine and methionine metabolism |
1.49 |
2.48e-1 |
43/50 (86%) |
AHCY;BHMT2;MAT2A;...
|
| Protein export |
1.44 |
2.77e-1 |
17/23 (73.91%) |
SEC61G;SPCS3;SRPRB;...
|
| Retinol metabolism |
1.43 |
2.79e-1 |
41/68 (60.29%) |
ALDH1A3;CYP1A1;UGT2B4;...
|
| Mucin type O-glycan biosynthesis |
1.39 |
3.17e-1 |
20/36 (55.56%) |
GALNT6;GALNT1;B4GALT5;...
|
| Nucleotide excision repair |
1.39 |
2.98e-1 |
40/47 (85.11%) |
PCNA;RFC5;MNAT1;...
|
| Proteasome |
1.38 |
2.89e-1 |
44/46 (95.65%) |
PSMB6;PSMD13;PSME4;...
|
| Ribosome biogenesis in eukaryotes |
1.37 |
2.70e-1 |
52/108 (48.15%) |
GNL3;NAT10;DKC1;...
|
| Primary immunodeficiency |
1.30 |
4.29e-1 |
33/38 (86.84%) |
ADA;DCLRE1C;LCK;...
|
| Cell cycle |
1.30 |
4.02e-1 |
110/124 (88.71%) |
PCNA;CDC20;MCM7;...
|
| Porphyrin and chlorophyll metabolism |
1.25 |
5.23e-1 |
23/43 (53.49%) |
PPOX;UGT2B4;ALAS2;...
|
| Base excision repair |
1.23 |
5.55e-1 |
29/33 (87.88%) |
PCNA;TDG;HMGB1;...
|
| Malaria |
1.22 |
5.43e-1 |
44/50 (88%) |
GYPA;THBS4;THBS1;...
|
| Propanoate metabolism |
1.17 |
6.86e-1 |
30/34 (88.24%) |
HIBCH;EHHADH;ACAT1;...
|
| Synthesis and degradation of ketone bodies |
1.17 |
6.61e-1 |
9/10 (90%) |
BDH2;ACAT1
|
| Cardiac muscle contraction |
1.14 |
7.59e-1 |
64/87 (73.56%) |
TPM4;COX7A1;CACNB2;...
|
| TGF-beta signaling pathway |
1.14 |
7.29e-1 |
81/94 (86.17%) |
LTBP1;SMURF2;HAMP;...
|
| Staphylococcus aureus infection |
1.12 |
7.64e-1 |
72/95 (75.79%) |
KRT19;DEFA5;DEFA6;...
|
| Butanoate metabolism |
1.11 |
7.78e-1 |
23/28 (82.14%) |
BDH2;EHHADH;ACAT1;...
|
| Thiamine metabolism |
1.09 |
8.20e-1 |
12/15 (80%) |
NFS1;ALPG;ALPL;...
|
| Steroid hormone biosynthesis |
1.08 |
8.09e-1 |
43/61 (70.49%) |
COMT;AKR1C4;CYP1A1;...
|
| Systemic lupus erythematosus |
1.06 |
8.09e-1 |
45/135 (33.33%) |
SNRPD1;SNRPB;C9;...
|
| Starch and sucrose metabolism |
1.05 |
8.15e-1 |
25/36 (69.44%) |
MGAM;GYG1;GYS2
|
| Non-homologous end-joining |
1.04 |
8.20e-1 |
11/13 (84.62%) |
DCLRE1C;MRE11
|
| Natural killer cell mediated cytotoxicity |
1.02 |
8.24e-1 |
99/131 (75.57%) |
LCK;BID;PIK3R1;...
|
| Endocrine and other factor-regulated calcium reabsorpti... |
-1.37 |
3.87e-1 |
49/53 (92.45%) |
CLTB;FXYD2;ATP2B3;...
|
| Ferroptosis |
-1.38 |
3.79e-1 |
36/41 (87.8%) |
PCBP2;SLC39A8;ATG5;...
|
| Circadian entrainment |
-1.38 |
3.81e-1 |
85/97 (87.63%) |
PER3;CAMK2B;GNG3;...
|
| Melanogenesis |
-1.38 |
3.91e-1 |
74/101 (73.27%) |
CAMK2B;CREB3L1;FZD1;...
|
| Long-term potentiation |
-1.40 |
3.77e-1 |
61/67 (91.04%) |
CREBBP;RPS6KA1;PPP1CA;...
|
| Fluid shear stress and atherosclerosis |
-1.41 |
3.81e-1 |
123/139 (88.49%) |
TRPV4;BMPR1B;CTNNB1;...
|
| Glucagon signaling pathway |
-1.42 |
3.58e-1 |
89/107 (83.18%) |
PHKG1;PPP4R3A;LDHB;...
|
| Choline metabolism in cancer |
-1.42 |
3.59e-1 |
84/98 (85.71%) |
SP1;DGKA;JUN;...
|
| Cholinergic synapse |
-1.43 |
3.68e-1 |
99/113 (87.61%) |
CAMK2B;CREB3L1;GNG3;...
|
| ECM-receptor interaction |
-1.43 |
3.68e-1 |
80/88 (90.91%) |
ITGB1;LAMC3;CD36;...
|
| Salivary secretion |
-1.44 |
3.81e-1 |
76/93 (81.72%) |
FXYD2;ATP2B3;GUCY1A1;...
|
| Prostate cancer |
-1.44 |
3.87e-1 |
93/97 (95.88%) |
CTNNB1;IKBKB;IKBKG;...
|
| Glycosaminoglycan degradation |
-1.45 |
3.82e-1 |
19/19 (100%) |
SGSH;HYAL1;GUSB;...
|
| Growth hormone synthesis, secretion and action |
-1.46 |
3.76e-1 |
108/119 (90.76%) |
CREB3L1;ITPR1;MAPK14;...
|
| Bacterial invasion of epithelial cells |
-1.47 |
3.65e-1 |
59/77 (76.62%) |
ELMO1;CTNNB1;CTTN;...
|
| Phagosome |
-1.47 |
3.70e-1 |
118/152 (77.63%) |
RAB5B;ATP6V1A;CD14;...
|
| Cholesterol metabolism |
-1.48 |
3.69e-1 |
44/50 (88%) |
ANGPTL8;CD36;VDAC1;...
|
| Cushing syndrome |
-1.50 |
3.34e-1 |
125/155 (80.65%) |
CAMK2B;CREB3L1;CDKN2C;...
|
| Ether lipid metabolism |
-1.50 |
3.50e-1 |
32/49 (65.31%) |
PLD3;PLA2G4C;PLA2G10;...
|
| Nitrogen metabolism |
-1.51 |
3.45e-1 |
16/17 (94.12%) |
CA6;GLUD1;CA7;...
|
| Aldosterone synthesis and secretion |
-1.52 |
3.66e-1 |
85/98 (86.73%) |
CAMK2B;CREB3L1;ITPR1;...
|
| Thyroid hormone synthesis |
-1.55 |
3.13e-1 |
66/75 (88%) |
GPX2;CREB3L1;ITPR1;...
|
| Cortisol synthesis and secretion |
-1.56 |
3.21e-1 |
58/65 (89.23%) |
CREB3L1;ITPR1;AGTR1;...
|
| Pertussis |
-1.57 |
3.24e-1 |
64/76 (84.21%) |
C4BPB;MAPK10;CD14;...
|
| Insulin resistance |
-1.59 |
3.20e-1 |
96/108 (88.89%) |
RPS6KA1;OGA;PPP1CA;...
|
| GnRH signaling pathway |
-1.59 |
3.62e-1 |
80/93 (86.02%) |
CAMK2B;ITPR1;EGR1;...
|
| Sphingolipid metabolism |
-1.61 |
3.63e-1 |
32/49 (65.31%) |
NEU1;SPHK1;SMPD1;...
|
| Lysosome |
-1.68 |
3.56e-1 |
115/128 (89.84%) |
CTSO;LIPA;ASAH1;...
|
| Protein digestion and absorption |
-1.74 |
3.30e-1 |
78/103 (75.73%) |
CELA3A;KCNN4;KCNK5;...
|
| Fatty acid elongation |
-1.83 |
3.30e-1 |
19/27 (70.37%) |
ACOT7;ACAA2;ELOVL1;...
|
